30/06/2021 |
Itolizumab-Plasmapheresis in patients with COVID-19 |
CIM |
Registered |
21/06/2023 |
VSSPs in renal carcinoma. |
CIM |
Registered |
21/05/2021 |
Nimotuzumab in COVID-19 |
CIM |
Registered |
15/07/2021 |
Rectal ozone therapy in high-risk symptomatic SARS-CoV-2 positive patients |
CPN |
Registered |
10/06/2021 |
SOBERANA PEDIATRIA |
FINLAY |
Registered |
01/07/2021 |
Evaluation of the safety and immunogenicity of the vaccine candidate "ABDALA" in children and adolescents |
CIGB |
Registered |
31/08/2021 |
Cocoa catabolites |
kmunoz |
Registered |
20/10/2021 |
CIMAvax-EGF/Lung cancer/Biomarkers/Prospective CT |
CIM |
Registered |
03/09/2021 |
MEÑIQUE Study |
CIGB |
Registered |
09/02/2023 |
PROCTOKINASE in acute pelvic inflammatory disease |
UCMM |
Registered |
31/03/2022 |
NUTRIRES2 |
SSA |
Registered |
27/04/2022 |
Evaluation of Clinical Performance of INFANTIX in a Maternity Hospital |
CNEURO |
Registered |
20/04/2022 |
Jusvinza in rheumatoid arthritis |
CIGB |
Registered |
16/05/2022 |
Effect of dietary fiber consumption on health |
kmunoz |
Registered |
06/12/2022 |
Nasal recombinant human interferon alfa-2b in ARI |
CIGB |
Registered |
20/09/2022 |
NeuroEPO in mild-moderate Alzheimer's disease |
CIM |
Registered |
22/09/2022 |
NeuroEPO in mild-moderate Alzheimer's disease amnesic variant |
CIM |
Registered |
29/07/2022 |
Nasalferon in ARI |
CIGB |
Registered |
24/04/2023 |
Phase III clinical trial: Dermofural®. Mild infection in diabetic foot ulcer |
CBQ |
Registered |
30/08/2022 |
Sinopharm-SOBERANA COVID-Cienfuegos |
FINLAY |
Registered |